CJF Warns Mothers on Topamax Increase Risk of Children with Oral Clefts
CJF Warns Mothers on Topamax Increase Risk of Children with Oral Clefts New information has been released by the FDA about potential Topamax birth defects indicates that mothers taking Topamax during pregnancy may have an increased risk of giving birth to children with oral cleft birth defects. Topamax is one of the most frequently prescribed antiepileptic medications for the treatment of epilepsy and migraine headaches, although the drug may no longer be considered safe for women of childbearing age. For more information about Topamax pregnancy risks or to contact a Topamax attorney, visit
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4